AngioDynamics Inc was incorporated in 1988 in Delaware. The Company designs, manufactures & sells medical, surgical & diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease & for use in oncology & surgical settings. Its product offerings fall within three product groupings: Peripheral Vascular, Vascular Access & Oncology/Surgery. The Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. Fluid Management product offering includes the NAMIC Fluid Management portfolio. The NAMIC product line includes an extensive offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers & interventional accessories. These devices are utilized together & allow clinicians to aspirate or inject contrast, saline, remove waste & monitor invasive blood pressures throughout the procedure. Venous products focus on the treatment of varicose veins & consist of its VenaCure EVLT laser system & Sotradecol. VenaCure EVLT laser system products are used in endovascular laser procedures to treat superficial venous disease (varicose veins). Sotradecol (sodium tetradecyl sulfate injection) is an FDA approved sclerosing drug that it distribute through a agreement with the manufacturer. Thrombus Management product offerings includes AngioVac & thrombolytic products. In fiscal 2013, the Company released its AngioVac venous drainage system which includes a Venous Drainage Cannula & Cardiopulmonary Bypass Circuit. The AngioVac devices are for use with other manufacturer's off-the-shelf pump, filter, & reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. Thrombolytic catheters are used to deliver thrombolytic agents, which are drugs that dissolve blood clots in hemodialysis access grafts, arteries, veins & surgical bypass grafts. The Company's other core peripheral vascular products include Angiographic products & accessories, drainage, micro access & other products. Angiographic products & accessories are used during peripheral vascular interventional procedures. Drainage products percutaneously drain abscesses & other fluid pockets. An abscess is a tender inflamed mass that typically must be drained by a physician. Image-guided vascular access, or IGVA, involves the use of imaging equipment to guide the placement of catheters that deliver short-term drug therapies, such as chemotherapeutic agents & antibiotics, into the central venous system. The BioFlo products incorporate Endexo Technology into the manufacturing & design of its Vascular Access products. A peripherally inserted central catheter, or PICC, is a long thin catheter that is inserted into a peripheral vein, typically in the upper arm, & until the catheter tip terminates in a large vein in the chest near the heart to obtain intravenous access. Ports are implantable devices utilized for the central venous administration of a variety of medical therapies & for blood sampling & diagnostic purposes. The Company markets a complete line of dialysis products that provide short & long-term vascular access for dialysis patients. The Oncology/Surgery product offerings include its Microwave Ablation products, its Radiofrequency Ablation (RFA) & its NanoKnife product lines. The Acculis Microwave Tissue Ablation (MTA) System complements full ablative technologies the Company offers. Radiofrequency Ablation (RFA) products use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors. The NanoKnife Ablation System is for the surgical ablation of soft tissue. Its device competitors include: Boston Scientific Corporation; Cook Medical; C.R. Bard; Medical Components, Inc.; TeleFlex Medical; Smiths Medical; Vascular Solutions; Medtronic; Merit Medical; Terumo Medical Corporation; Vascular Solutions & Total Vein Systems.
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.